Eli Lilly Drug Fails to Prevent Alzheimer ’s in Study
Eli Lilly’s solanezumab was tested in more than 1,100 people with no signs of cognitive problems but who had clumps of the amyloid protein in their brains. An experimental drug from Eli Lilly & Co. failed to prevent memory loss in a study of healthy older people with a high risk of developing…#elilillys #elilillyco #lilly (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2023 Category: Consumer Health News Source Type: news
Could the Mediterranean Diet Help People With MS?
New research finds that a diet rich in veggies, fruit, fish and healthy fat reduced their risk of developing memory loss as well as losing the ability to concentrate, learn new things or make decisions. (Source: WebMD Health)
Source: WebMD Health - March 2, 2023 Category: Consumer Health News Source Type: news
Middle-Aged Smokers Face Higher Risk for Dementia Middle-Aged Smokers Face Higher Risk for Dementia
Middle-aged smokers are far more likely to report having memory loss and confusion than nonsmokers.Quick Take (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - February 27, 2023 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
Dementia-related pain: What caregivers need to know
Dementia isn't a specific disease. Instead, it describes a collection of symptoms that affect a person's thinking and social abilities enough to interfere with daily life. There are more than 55 million people worldwide living with dementia. Of these, 50% to 60% have Alzheimer's disease. Dementia is the seventh leading cause of death worldwide. There is a constellation of dementia symptoms, and memory loss is the primary feature. Other common symptoms are physical functional decline… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 22, 2023 Category: Databases & Libraries Source Type: news
Bruce Willis Has Frontotemporal Dementia. Here ’ s What It Is
In an Instagram post, Bruce Willis’ family revealed that the actor has been diagnosed with frontotemporal dementia (FTD). The diagnosis comes nearly a year after his family revealed Willis has aphasia, which is characterized by difficulty speaking.
“Since we announced Bruce’s diagnosis of aphasia in spring 2022, Bruce’s condition has progressed and we now have a more specific diagnosis: frontotemporal dementia (known as FTD),” the family said in its statement, which was also posted on the Association for Frontotemporal Degeneration’s website.
Here’s what to know about the condition...
Source: TIME: Health - February 17, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Disease Explainer healthscienceclimate Source Type: news
Five 'early' signs of frontotemporal dementia as Bruce Willis diagnosed with the condition
Memory loss problems, which are the key signs of many dementia types, only tend to occur later on in frontotemporal dementia patients. (Source: Daily Express - Health)
Source: Daily Express - Health - February 17, 2023 Category: Consumer Health News Source Type: news
Associations between blackout drinking and self-reported everyday cognition among young adults - Linden-Carmichael AN, Mogle J, Miller SE.
INTRODUCTION: Blackout drinking, or alcohol-induced memory loss during at least some part of a drinking occasion, is common among young adults and associated with negative alcohol-related consequences. One potential unique effect of blackout drinking episo... (Source: SafetyLit)
Source: SafetyLit - February 13, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Suffering with memory loss? It could be a sign your cholesterol is too high
One study of more than 3,600 people found that low levels of "good" cholesterol are linked with diminished memory by the age of 60, raising the risk of dementia. (Source: Daily Express - Health)
Source: Daily Express - Health - January 28, 2023 Category: Consumer Health News Source Type: news
Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI ® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
RARITAN, New Jersey, January 27, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) versus pomalidomide, bortezomib, and dexamethasone (PVd) or daratumumab, pomalidomide, and dexamethasone (DPd) for the treatment of patients with relapsed and lenalidomide-refractory multiple myeloma met its primary endpoint of significant improvement in progression-free survival (PFS) at the first pre-specified interim analysis. As a result of meeting the primary endpoint, the Independent Data Monitoring Commi...
Source: Johnson and Johnson - January 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
New study finds 6 ways to slow memory decline and lower dementia risk
A new study from China identified “healthy lifestyle factors” associated with slower memory loss and a lower risk of dementia in elderly people. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - January 26, 2023 Category: Consumer Health News Authors: Annabelle Timsit Source Type: news
Tachycardia is a symptom of 'later' stage severe fatty liver disease - other signs
Some might also experience forgetfulness, memory loss, confusion and drowsiness as the liver is "struggling to function". (Source: Daily Express - Health)
Source: Daily Express - Health - January 25, 2023 Category: Consumer Health News Source Type: news
Initial Symptoms Could Predict How Fast Alzheimer's Progresses
WEDNESDAY, Jan. 25, 2023 -- Memory loss is the most common symptom associated with Alzheimer ’s disease — the terrifying prospect of slowly forgetting yourself and everything around you.
But people who exhibit memory loss early on in their... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 25, 2023 Category: General Medicine Source Type: news
Asthma Drug Helps Mice Retrieve Memories "Lost" to Sleep Deprivation
A study finds roflumilast can reverse sleep deprivation-induced amnesia in mice, hinting at pathways to treating memory loss in people. (Source: The Scientist)
Source: The Scientist - January 25, 2023 Category: Science Tags: News & Opinion Source Type: news
UNISON demands action on migrant worker health surcharge
On the third day of UNISON’s national Black members’ conference, delegates passed several key motions in support of migrant rights.
One of the motions demanded that the government hold to its promise of reimbursing the immigration health surcharge (IHS) paid by migrant workers.
The IHS is a health tax on migrants. It’s an extra payment that migrant workers and their families have to make to the NHS, in addition to paying their taxes.
The surcharge was introduced in 2015 at £200 a year for each person. In 2018, it was doubled to £400 and in 2020, it increased to £624.
During the COVID-19 pandemic, under press...
Source: UNISON Health care news - January 24, 2023 Category: UK Health Authors: Janey Starling Tags: Article News 2023 National Black Members Conference migrant workers Source Type: news
FDA Approves Lecanemab, a New Alzheimer ’s Drug
On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages.
Lecanemab, which will be available under the name Leqembi, can slow the cognitive decline associated with Alzheimer’s disease by 27%, according to data submitted to the FDA by the drug’s developers, Eisai and Biogen. It’s only the second medication to show any improvement in neurodegeneration, a key criterion in the FDA’s consideration for approval.
“For a long time, this is what we have been looking for,” says Dr. Sam Gandy, professor of neurology and psychi...
Source: TIME: Health - January 6, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
